York University has received an $8.7M grant from Wellcome Trust to support research on the global health threat of antimicrobial resistance (AMR). Through YorkU’s AMR Policy Accelerator, a project initiated by the university’s Global Strategy Lab, researchers will produce academic papers, conduct customized research, and provide advisory services to governments and civil-society organizations that request information on AMR policy, implementation, and evaluation. A GSL team will focus on AMR and how its three main points of spread – human, animal, and environmental – intersect. “With COVID-19, with that many people in hospital — intubated and experiencing secondary bacterial infections — that’s created massive opportunities for more antimicrobial resistance to develop,” said GSL director Steven J Hoffman. “If decision-makers don’t implement sound policy based on evidence, we may be facing the next crisis without these vital treatments.” YorkU Note: Archived stories may contain dead links or be missing source links.